Apimeds Pharmaceuticals Inc. (APUS)
Market Closed
30 Jul, 20:00
AMEX AMEX Primary $
4. 92
-0.83
-14.4348%
$
12.07M Market Cap
- P/E Ratio
- Div Yield
124,356 Volume
- Eps
$ 5.75
Previous Close Want to track APUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Apimeds Pharmaceuticals Inc. (APUS) Statistics
Valuation metrics
Market Cap 12.07M
Enterprise value 17.08M
Trailing P/E (ttm) -0.09
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.07
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 33.67K
Average volume (90 days) 179.96K
Price summary
52-Week low 0.62
52-Week high 40.31
Beta -
50-Day moving average 1.24
200-Day moving average 1.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 24 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.29%
Return on equity -0.55%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -26.21
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.6
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 0.9%
Book value per share (mrq) 81.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
